HomeCompareBLCM vs YUM

BLCM vs YUM: Dividend Comparison 2026

BLCM yields 2675.59% · YUM yields 1.86%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BLCM wins by $153201888663.77M in total portfolio value
10 years
BLCM
BLCM
● Live price
2675.59%
Share price
$0.07
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$153201888663.88M
Annual income
$142,709,556,416,008,380.00
Full BLCM calculator →
YUM
YUM
● Live price
1.86%
Share price
$154.59
Annual div
$2.88
5Y div CAGR
51.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$107.9K
Annual income
$40,443.52
Full YUM calculator →

Portfolio growth — BLCM vs YUM

📍 BLCM pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBLCMYUM
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BLCM + YUM cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BLCM pays
YUM pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BLCM
Annual income on $10K today (after 15% tax)
$227,424.75/yr
After 10yr DRIP, annual income (after tax)
$121,303,122,953,607,120.00/yr
YUM
Annual income on $10K today (after 15% tax)
$158.35/yr
After 10yr DRIP, annual income (after tax)
$34,376.99/yr
At 15% tax rate, BLCM beats the other by $121,303,122,953,572,740.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BLCM + YUM for your $10,000?

BLCM: 50%YUM: 50%
100% YUM50/50100% BLCM
Portfolio after 10yr
$76600944331.99M
Annual income
$71,354,778,208,024,420.00/yr
Blended yield
93.15%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on YUM right now

BLCM
Analyst Ratings
9
Buy
Consensus: Buy
Altman Z
-129.7
Piotroski
1/9
YUM
Analyst Ratings
18
Buy
30
Hold
3
Sell
Consensus: Hold
Price Target
$173.15
+12.0% upside vs current
Range: $158.00 — $190.00
Altman Z
2.6
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BLCM buys
0
YUM buys
0
No recent congressional trades found for BLCM or YUM in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBLCMYUM
Forward yield2675.59%1.86%
Annual dividend / share$2.00$2.88
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%51.4%
Portfolio after 10y$153201888663.88M$107.9K
Annual income after 10y$142,709,556,416,008,380.00$40,443.52
Total dividends collected$152471773366.59M$81.2K
Payment frequencyquarterlyquarterly
SectorStockConsumer Discretionary
Analyst consensusBuyHold

Year-by-year: BLCM vs YUM ($10,000, DRIP)

YearBLCM PortfolioBLCM Income/yrYUM PortfolioYUM Income/yrGap
1← crossover$278,259$267,558.53$10,982$282.06+$267.3KBLCM
2$7,255,722$6,957,985.27$12,189$438.29+$7.24MBLCM
3$177,326,927$169,563,304.48$13,731$688.32+$177.31MBLCM
4$4,062,692,158$3,872,952,346.55$15,789$1,097.12+$4062.68MBLCM
5$87,274,395,543$82,927,314,933.13$18,679$1,785.08+$87274.38MBLCM
6$1,758,278,261,281$1,664,894,658,050.44$22,975$2,988.18+$1758278.24MBLCM
7$33,228,917,517,770$31,347,559,778,199.17$29,784$5,200.49+$33228917.49MBLCM
8$589,221,826,220,148$553,666,884,476,134.20$41,408$9,539.16+$589221826.18MBLCM
9$9,805,917,988,665,990$9,175,450,634,610,432.00$63,071$18,765.27+$9805917988.60MBLCM
10$153,201,888,663,881,000$142,709,556,416,008,380.00$107,930$40,443.52+$153201888663.77MBLCM

BLCM vs YUM: Complete Analysis 2026

BLCMStock

Bellicum Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel cellular immunotherapies for the treatment of hematological cancers and solid tumors in the United States and internationally. The company's clinical product candidates include BPX-601, an autologous GoCAR-T product candidate, which is in Phase 1/2 clinical trials for the treatment of solid tumors expressing the prostate stem cell antigen; and BPX-603, a dual-switch GoCAR-T product candidate that is in Phase 1/2 clinical trials to treat solid tumors that express the human epidermal growth factor receptor 2 antigens. Its clinical product candidates also include Rivo-cel, an allogeneic T cell product candidate intended to enhance outcomes in the treatment of leukemias, lymphomas, and inherited blood disorders. It has collaboration and license agreements with Adaptimmune Therapeutics plc; Agensys, Inc.; BioVec Pharma, Inc.; ARIAD Pharmaceuticals, Inc.; and Baylor College of Medicine. Bellicum Pharmaceuticals, Inc. was incorporated in 2004 and is headquartered in Houston, Texas.

Full BLCM Calculator →

YUMConsumer Discretionary

YUM! Brands, Inc., together with its subsidiaries, develops, operates, and franchises quick service restaurants worldwide. It operates through four segments: the KFC Division, the Taco Bell Division, the Pizza Hut Division, and the Habit Burger Grill Division. The company operates restaurants under the KFC, Pizza Hut, Taco Bell, and The Habit Burger Grill brands, which specialize in chicken, pizza, made-to-order chargrilled burgers, sandwiches, Mexican-style food categories, and other food products. As of December 31, 2021, it had 26,934 KFC units; 18,381 Pizza Hut units; 7,791 Taco Bell units; and 318 The Habit Burger Grill units in approximately 157 countries and territories. The company was formerly known as TRICON Global Restaurants, Inc. and changed its name to YUM! Brands, Inc. in May 2002. YUM! Brands, Inc. was incorporated in 1997 and is headquartered in Louisville, Kentucky.

Full YUM Calculator →
📬

Get this BLCM vs YUM comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BLCM vs SCHDBLCM vs JEPIBLCM vs OBLCM vs KOBLCM vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.